Last10K.com

Athenex, Inc. (ATNX) SEC Filing 8-K Material Event for the period ending Wednesday, November 16, 2022

Athenex, Inc.

HISTORY TOOLS
CIK: 1300699 Ticker: ATNX

View differences made from one to another to evaluate Athenex, Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Athenex, Inc..

Continue

Assess how Athenex, Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Athenex, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2022 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Financial Statements, Disclosures and Schedules

Inside this 8-K Corporate News

Document And Entity Information

Material Contracts, Statements, Certifications & more

Athenex, Inc. provided additional information to their SEC Filing as exhibits

Exhibit 10.1: Material Contract
Exhibit 99.1: Additional Exhibits
Ticker: ATNX
CIK: 1300699
Form Type: 8-K Corporate News
Accession Number: 0001193125-22-289550
Submitted to the SEC: Mon Nov 21 2022 8:16:01 AM EST
Accepted by the SEC: Mon Nov 21 2022
Period: Wednesday, November 16, 2022
Industry: Pharmaceutical Preparations
Events:
  1. Change in Assets
  2. Financial Exhibit
  3. New Agreement

External Resources:
Stock Quote
Social Media
SEC.gov

Bookmark the Permalink:
https://last10k.com/sec-filings/atnx/0001193125-22-289550.htm